Enterolactone: A novel radiosensitizer for human breast cancer cell lines through impaired DNA repair and increased apoptosis

Toxicology and Applied Pharmacology

Volumn 313, Issue , 2016, Pages 180-194

  Bigdeli, Bahareh ^a   Goliaei, Bahram ^a   Masoudi Khoram, Nastaran ^a   Jooyan, Najmeh ^a   Nikoofar, Alireza ^b   Rouhani, Maryam ^c   Haghparast, Abbas ^d   Mamashli, Fatemeh ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c INSTITUTE FOR ADVANCED STUDIES IN BASIC SCIENCES IASBS   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; Chromosomal aberrations; DNA repair; Enterolactone; Micronuclei; Radiosensitizer

Indexed keywords

ENTEROLACTONE; RADIOSENSITIZING AGENT; 2,3-BIS(3'-HYDROXYBENZYL)BUTYROLACTONE; GAMMA BUTYROLACTONE; LIGNAN;

APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELL SURVIVAL; CELL VIABILITY; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DAMAGE; CLONOGENIC ASSAY; COMET ASSAY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINESIS; DNA DAMAGE; DNA REPAIR; DRUG CYTOTOXICITY; DRUG EFFECT; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IC50; MDA MB 231 CELL LINE; MICRONUCLEUS TEST; MTT ASSAY; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIVITY; RADIOSENSITIZATION; T47D CELL LINE; X IRRADIATION; ANALOGS AND DERIVATIVES; BREAST TUMOR; DRUG EFFECTS; FEMALE; PATHOLOGY; TUMOR CELL LINE;

4-BUTYROLACTONE; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA REPAIR; FEMALE; HUMANS; LIGNANS; RADIATION-SENSITIZING AGENTS;

EID: 84994718691     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2016.10.021     Document Type: Article

References (66)

1. Armstrong, D.K., Gordon, G.B., Hilton, J., Streeper, R.T., Colvin, O.M., Davidson, N.E., Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance. Cancer Res. 52:6 (1992), 1416–1421 ( https://www.ncbi.nlm.nih.gov/pubmed/1540950).
2. Begg, A.C., Stewart, F.A., Vens, C., Strategies to improve radiotherapy with targeted drugs. Nat. Rev. Cancer 11:4 (2011), 239–253, 10.1038/nrc3007.
3. Birben, E., Sahiner, U.M., Sackesen, C., Erzurum, S., Kalayci, O., Oxidative stress and antioxidant defense. World Allergy Organ. J., 5(1), 2012, 1, 10.1097/WOX.0b013e3182439613.
4. Carlson, D.J., Stewart, R.D., Li, X.A., Jennings, K., Wang, J.Z., Guerrero, M., Comparison of in vitro and in vivo α/β ratios for prostate cancer. Phys. Med. Biol., 49, 2004, 4477, 10.1088/0031-9155/49/19/003.
5. Chen, J., Stavro, P.M., Thompson, L.U., Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr. Cancer 43:2 (2002), 187–192, 10.1207/S15327914NC432_9.
6. Chen, L.-H., Fang, J., Li, H., Demark-Wahnefried, W., Lin, X., Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway. Mol. Cancer Ther. 6:9 (2007), 2581–2590, 10.1158/1535-7163.MCT-07-0220.
7. Chen, L.-H., Fang, J., Sun, Z., Li, H., Wu, Y., Demark-Wahnefried, W., Lin, X., Enterolactone inhibits insulin-like growth factor-1 receptor signaling in human prostatic carcinoma PC-3 cells. J. Nutr. 139:4 (2009), 653–659, 10.3945/jn.108.101832.
8. Chendil, D., Ranga, R.S., Meigooni, D., Sathishkumar, S., Ahmed, M.M., Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23:8 (2004), 1599–1607, 10.1038/sj.onc.1207284.
9. Collins, A.R., Oscoz, A.A., Brunborg, G., Gaivao, I., Giovannelli, L., Kruszewski, M., Smith, C.C., Štětina, R., The comet assay: topical issues. Mutagenesis 23:3 (2008), 143–151, 10.1093/mutage/gem051.
10. Danbara, N., Yuri, T., Tsujita-Kyutoku, M., Tsukamoto, R., Uehara, N., Tsubura, A., Enterolactone induces apoptosis and inhibits growth of Colo 201 human colon cancer cells both in vitro and in vivo. Anticancer Res. 25:3B (2005), 2269–2276 ( http://www.ncbi.nlm.nih.gov/pubmed/16158974).
11. Dejeans, N., Glorieux, C., Guenin, S., Beck, R., Sid, B., Rousseau, R., Bisig, B., Delvenne, P., Calderon, P.B., Verrax, J., Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: implications for tumor recurrence. Free Radic. Biol. Med. 52:6 (2012), 993–1002, 10.1016/j.freeradbiomed.2011.12.019.
12. Deng, R., Tang, J., Ma, J., Chen, S., Xia, L., Zhou, W., Li, D., Feng, G., Zeng, Y., Zhu, X., PKB/Akt promotes DSB repair in cancer cells through upregulating Mre11 expression following ionizing radiation. Oncogene 30:8 (2011), 944–955, 10.1038/onc.2010.467.
13. Denizot, F., Lang, R., Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89:2 (1986), 271–277 ( https://www.ncbi.nlm.nih.gov/pubmed/3486233).
14. Djavid, G.E., Goliaie, B., Nikoofar, A., Analysis of radiomodulatory effect of low-level laser irradiation by clonogenic survival assay. Photomed. Laser Surg. 33:9 (2015), 452–459, 10.1089/pho.2015.3893.
15. Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., Bray, F., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136:5 (2015), E359–E386 ( http://globocan.iarc.fr/Pages/references.aspx).
16. Franken, N.A., Rodermond, H.M., Stap, J., Haveman, J., Van Bree, C., Clonogenic assay of cells in vitro. Nat. Protoc. 1:5 (2006), 2315–2319, 10.1038/nprot.2006.339.
17. Garg, A.K., Buchholz, T.A., Aggarwal, B.B., Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid. Redox Signal. 7:11–12 (2005), 1630–1647, 10.1089/ars.2005.7.1630.
18. Ghavami, L., Goliaei, B., Taghizadeh, B., Nikoofar, A., Effects of barley β-glucan on radiation damage in the human hepatoma cell line HepG2. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 775 (2014), 1–6, 10.1016/j.mrgentox.2014.09.005.
19. Gong, X.-M., Zhang, Q., Torossian, A., Cao, J.-P., Fu, S., Selective radiosensitization of human cervical cancer cells and normal cells by artemisinin through the abrogation of radiation-induced G2 block. Int. J. Gynecol. Cancer 22:5 (2012), 718–724, 10.1097/IGC.0b013e31824a67c9.
20. Hall, E., Giaccia, A., Radiobiology for the Radiologist. 2006, Lippincott Williams & Wilkins, Philadelphia ( https://www.amazon.com/Radiobiology-Radiologist-Eric-J-Hall/dp/1608311937).
21. Han, Y., Cui, Z., Li, Y.-H., Hsu, W.-H., Lee, B.-H., In vitro and in vivo anticancer activity of pardaxin against proliferation and growth of oral squamous cell carcinoma. Mar. Drugs, 14(1), 2015, 2, 10.3390/md14010002.
22. He, J., Chen, W., Jin, L., Jin, H., Comparative evaluation of the in vitro micronucleus test and the comet assay for the detection of genotoxic effects of X-ray radiation. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 469:2 (2000), 223–231, 10.1016/S1383-5718(00)00077-2.
23. Hecht, F., Cazarin, J.M., Lima, C.E., Faria, C.C., da Costa Leitão, A.A., Ferreira, A.C., Carvalho, D.P., Fortunato, R.S., Redox homeostasis of breast cancer lineages contributes to differential cell death response to exogenous hydrogen peroxide. Life Sci. 158 (2016), 7–13, 10.1016/j.lfs.2016.06.016.
24. Hsu, T., Genetic predisposition to cancer with special reference to mutagen sensitivity. In Vitro Cell. Dev. Biol. 23:9 (1987), 591–603, 10.1007/BF02621067.
25. Huang, G., Wang, H., Yang, L.-X., Enhancement of radiation-induced DNA damage and inhibition of its repair by a novel camptothecin analog. Anticancer Res. 30:3 (2010), 937–944 ( http://www.ncbi.nlm.nih.gov/pubmed/20393017).
26. Iliakis, G., Wang, H., Perrault, A., Boecker, W., Rosidi, B., Windhofer, F., Wu, W., Guan, J., Terzoudi, G., Pantelias, G., Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet. Genome Res. 104:1–4 (2004), 14–20, 10.1159/000077461.
27. Jameel, J., Rao, V., Cawkwell, L., Drew, P., Radioresistance in carcinoma of the breast. Breast 13:6 (2004), 452–460, 10.1016/j.breast.2004.08.004.
28. Javvadi, P., Segan, A.T., Tuttle, S.W., Koumenis, C., The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol. Pharmacol. 73:5 (2008), 1491–1501, 10.1124/mol.107.043554.
29. Javvadi, P., Hertan, L., Kosoff, R., Datta, T., Kolev, J., Mick, R., Tuttle, S.W., Koumenis, C., Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells. Cancer Res. 70:5 (2010), 1941–1950, 10.1158/0008-5472.CAN-09-3025.
30. Jungeström, M.B., Thompson, L.U., Dabrosin, C., Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin. Cancer Res. 13:3 (2007), 1061–1067, 10.1158/1078-0432.CCR-06-1651.
31. Kasten-Pisula, U., Windhorst, S., Dahm-Daphi, J., Mayr, G., Dikomey, E., Radiosensitization of tumour cell lines by the polyphenol Gossypol results from depressed double-strand break repair and not from enhanced apoptosis. Radiother. Oncol. 83:3 (2007), 296–303, 10.1016/j.radonc.2007.04.024.
32. Kesari, S., Advani, S.J., Lawson, J.D., Kahle, K.T., Ng, K., Carter, B., Chen, C.C., DNA damage response and repair: insights into strategies for radiation sensitization of gliomas. Future Oncol. 7:11 (2011), 1335–1346, 10.2217/fon.11.111.
33. Khoram, N.M., Bigdeli, B., Nikoofar, A., Goliaei, B., Caffeic acid phenethyl ester increases radiosensitivity of estrogen receptor-positive and-negative breast cancer cells by prolonging radiation-induced DNA damage. J. Breast Cancer 19:1 (2016), 18–25, 10.4048/jbc.2016.19.1.18.
34. Koller, V.J., Auwärter, V., Grummt, T., Moosmann, B., Mišík, M., Knasmüller, S., Investigation of the in vitro toxicological properties of the synthetic cannabimimetic drug CP-47,497-C8. Toxicol. Appl. Pharmacol. 277:2 (2014), 164–171, 10.1016/j.taap.2014.03.014.
35. Kubota, H., Suzuki, T., Lu, J., Takahashi, S., Sugita, K., Sekiya, S., Suzuki, N., Increased expression of GRP94 protein is associated with decreased sensitivity to X-rays in cervical cancer cell lines. Int. J. Radiat. Biol. 81:9 (2005), 701–709, 10.1080/09553000500434727.
36. Lee, J.-G., Madden, M.C., Reed, W., Adler, K., Devlin, R., The use of the single cell gel electrophoresis assay in detecting DNAsingle strand breaks in lung cells in vitro. Toxicol. Appl. Pharmacol. 141:1 (1996), 195–204, 10.1006/taap.1996.0276.
37. Li, B., Cheng, X.L., Yang, Y.P., Li, Z.Q., GRP78 mediates radiation resistance of a stem cell-like subpopulation within the MCF-7 breast cancer cell line. Oncol. Rep. 30:5 (2013), 2119–2126, 10.3892/or.2013.2710.
38. Liegler, T.J., Hyun, W., Yen, T., Stites, D.P., Detection and quantification of live, apoptotic, and necrotic human peripheral lymphocytes by single-laser flow cytometry. Clin. Diagn. Lab. Immunol. 2:3 (1995), 369–376 ( http://www.ncbi.nlm.nih.gov/pubmed/7664185).
39. Lin, X., Switzer, B.R., Demark-Wahnefried, W., Effect of mammalian lignans on the growth of prostate cancer cell lines. Anticancer Res. 21:6A (2000), 3995–3999 ( http://www.ncbi.nlm.nih.gov/pubmed/11911282).
40. Lin, C., Yu, Y., Zhao, H.-g., Yang, A., Yan, H., Cui, Y., Combination of quercetin with radiotherapy enhances tumor radiosensitivity in vitro and in vivo. Radiother. Oncol. 104:3 (2012), 395–400, 10.1016/j.radonc.2011.10.023.
41. Liu, X., Sun, C., Jin, X., Li, P., Ye, F., Zhao, T., Gong, L., Li, Q., Genistein enhances the radiosensitivity of breast cancer cells via G2/M cell cycle arrest and apoptosis. Molecules 18:11 (2013), 13200–13217, 10.3390/molecules181113200.
42. Liu, X., Sun, C., Liu, B., Jin, X., Li, P., Zheng, X., Zhao, T., Li, F., Li, Q., Genistein mediates the selective radiosensitizing effect in NSCLC A549 cells via inhibiting methylation of the keap1 gene promoter region. Oncotarget 7 (2016), 27267–27279, 10.18632/oncotarget.8403.
43. Luo, J., Zhu, W., Tang, Y., Cao, H., Zhou, Y., Ji, R., Zhou, X., Lu, Z., Yang, H., Zhang, S., Artemisinin derivative artesunate induces radiosensitivity in cervical cancer cells in vitro and in vivo. Radiat. Oncol., 9(1), 2014, 1, 10.1186/1748-717X-9-84.
44. Malik, A., Sultana, M., Qazi, A., Qazi, M.H., Parveen, G., Waquar, S., Ashraf, A.B., Rasool, M., Role of natural radiosensitizers and cancer cell radioresistance: an update. Anal. Cell. Pathol., 2016, 2016, 10.1155/2016/6146595.
45. McCann, M.J., Rowland, I.R., Roy, N.C., Anti-proliferative effects of physiological concentrations of enterolactone in models of prostate tumourigenesis. Mol. Nutr. Food Res. 57:2 (2013), 212–224, 10.1002/mnfr.201200362.
46. McCann, M.J., Rowland, I.R., Roy, N.C., The anti-proliferative effects of enterolactone in prostate cancer cells: evidence for the role of DNA Licencing genes, mi-R106b cluster expression, and PTEN dosage. Nutrients 6:11 (2014), 4839–4855, 10.3390/nu6114839.
47. Meschini, R., Berni, A., Ortenzi, V., Mancinelli, P., Palitti, F., Relation between DNA repair, apoptosis and chromosomal aberrations in presence of pifithrin-α, an inhibitor of p53. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 701:1 (2010), 92–97, 10.1016/j.mrgentox.2010.03.017.
48. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:1–2 (1983), 55–63 ( https://www.ncbi.nlm.nih.gov/pubmed/6606682).
49. Nambiar, D., Rajamani, P., Singh, R.P., Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy. Mutat. Res. Rev. Mutat. Res. 728:3 (2011), 139–157, 10.1016/j.mrrev.2011.07.005.
50. Nami, B., Ghasemi-Dizgah, A., Vaseghi, A., Overexpression of molecular chaperons GRP78 and GRP94 in CD44hi/CD24lo breast cancer stem cells. Bioimpacts, 6(2), 2016, 105, 10.15171/bi.2016.15.
51. Rashid, A., Liu, C., Sanli, T., Tsiani, E., Singh, G., Bristow, R.G., Dayes, I., Lukka, H., Wright, J., Tsakiridis, T., Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways. Radiat. Oncol., 6(1), 2011, 1, 10.1186/1748-717X-6-144.
52. Ribble, D., Goldstein, N.B., Norris, D.A., Shellman, Y.G., A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol., 5(1), 2005, 12, 10.1186/1472-6750-5-12.
53. Saarinen, N.M., Huovinen, R., Wärri, A., Mäkelä, S.I., Valentín-Blasini, L., Sjöholm, R., Ämmälä, J., Lehtilä, R., Eckerman, C., Collan, Y.U., Enterolactone inhibits the growth of 7, 12-dimethylbenz (a) anthracene-induced mammary carcinomas in the rat 1 supported by the National Technology Agency of Finland (TEKES) through projects 51583/00 and 40078/01. 1. Mol. Cancer Ther. 1:10 (2002), 869–876 ( http://www.ncbi.nlm.nih.gov/pubmed/12492120).
54. Saarinen, N.M., Abrahamsson, A., Dabrosin, C., Estrogen-induced angiogenic factors derived from stromal and cancer cells are differently regulated by enterolactone and genistein in human breast cancer in vivo. Int. J. Cancer 127:3 (2010), 737–745, 10.1002/ijc.25052.
55. Smith, L., Qutob, O., Watson, M.B., Beavis, A.W., Potts, D., Welham, K.J., Garimella, V., Lind, M.J., Drew, P.J., Cawkwell, L., Proteomic identification of putative biomarkers of radiotherapy resistance: a possible role for the 26S proteasome?. Neoplasia 11:11 (2009), 1194–1207, 10.1593/neo.09902.
56. Soleymanifard, S., Bahreyni, M.T.T., Comparing the level of bystander effect in a couple of tumor and normal cell lines. J. Med. Phys., 37(2), 2012, 102, 10.4103/0971-6203.94745.
57. Speers, C., Zhao, S., Liu, M., Bartelink, H., Pierce, L.J., Feng, F.Y., Development and validation of a novel radiosensitivity signature in human breast cancer. Clin. Cancer Res. 21:16 (2015), 3667–3677, 10.1158/1078-0432.CCR-14-2898.
58. Taghizadeh, B., Ghavami, L., Nikoofar, A., Goliaei, B., Equol as a potent radiosensitizer in estrogen receptor-positive and-negative human breast cancer cell lines. Breast Cancer 22:4 (2015), 382–390, 10.1007/s12282-013-0492-0.
59. Tang, Y., Simoneau, A.R., Xie, J., Shahandeh, B., Zi, X., Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53. Cancer Prev. Res. 1:6 (2008), 439–451, 10.1158/1940-6207.CAPR-08-0165.
60. Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., Jemal, A., Global cancer statistics, 2012. CA Cancer J. Clin. 65:2 (2015), 87–108, 10.3322/caac.21262.
61. Valerie, K., Yacoub, A., Hagan, M.P., Curiel, D.T., Fisher, P.B., Grant, S., Dent, P., Radiation-induced cell signaling: inside-out and outside-in. Mol. Cancer Ther. 6:3 (2007), 789–801, 10.1158/1535-7163.MCT-06-0596.
62. Van Goethem, F., Lison, D., Kirsch-Volders, M., Comparative evaluation of the in vitro micronucleus test and the alkaline single cell gel electrophoresis assay for the detection of DNA damaging agents: genotoxic effects of cobalt powder, tungsten carbide and cobalt–tungsten carbide. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 392:1 (1997), 31–43, 10.1016/S0165-1218(97)00043-8.
63. Wang, M., Wey, S., Zhang, Y., Ye, R., Lee, A.S., Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid. Redox Signal. 11:9 (2009), 2307–2316, 10.1089/ars.2009.2485.
64. Wang, B.-F., Dai, Z.-J., Wang, X.-J., Bai, M.-H., Lin, S., Ma, H.-B., Wang, Y.-L., Song, L.-Q., Ma, X.-L., Zan, Y., Saikosaponin-d increases the radiosensitivity of smmc-7721 hepatocellular carcinoma cells by adjusting the g0/g1 and g2/m checkpoints of the cell cycle. BMC Complement. Altern. Med., 13(1), 2013, 1, 10.1186/1472-6882-13-263.
65. Wang, L., Long, L., Wang, W., Liang, Z., Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo. J. Pharmacol. Sci. 129:4 (2015), 216–225, 10.1016/j.jphs.2015.11.001.
66. Yuan, S.-S.F., Yang, Y.-K., Chen, H.-W., Chung, Y.-F., Chang, H.-L., Su, J.-H., Neocarzinostatin-induced Rad51 nuclear focus formation is cell cycle regulated and aberrant in AT cells. Toxicol. Appl. Pharmacol. 192:3 (2003), 231–236, 10.1016/S0041-008X(03)00013-9.